GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now gaining a prominent focus in healthcare research, largely due to its impressive impact on managing diseases such as adult-onset diabetes and obesity. Ongoing studies have demonstrated that in addition to glucose control, GLP-1 drugs offer promise for cardiovascular health and per… Read More